Objective-Increasing evidence suggests that chronic inflammation contributes to atherogenesis, and that acute inflammatory events cause plaque rupture, thrombosis, and myocardial infarction. The present studies examined how inflammatory factors, such as interferon-␥ (IFN␥), cause increased sensitivity to apoptosis in vascular lesion cells.
A dvancing age, the single strongest risk factor for cardiovascular disease, favors lesion formation in response to injuries resulting from hyperlipidemia, hypertension, and smoking. Particularly in early lesions, apoptosis of monocyte/ macrophages contributes to the accumulation of extracellular lipid and proteins. 1 In later stages, smooth muscle cell-like (SMC-like)/myofibroblasts encapsulate the lipid-rich regions, and their persistence contributes to matrix accumulation and negative remodeling. 2 However, when apoptosis occurs in the cap of advanced lesions, the plaque is prone to rupture, thereby triggering thrombosis and myocardial infarction. Increased apoptosis is frequently associated with clinically unstable coronary artery lesions, 3 and there is strong evidence that apoptosis is a major contributing factor to plaque instability and sudden coronary death. 4, 5 Inflammation is intimately linked to the Fas/Fas ligand system, which can either drive proliferation or induce apoptosis of lymphocytes based on the particular context. 6 Cells within human lesions express Fas (CD95), the receptor for Fas ligand, a potent proapoptotic factor. 7 Inflammatory regions, which contain lymphocyte-derived interferon-␥ (IFN␥) and Fas ligand, exhibit the highest levels of SMC-like apoptosis. 8 Activated macrophages induce apoptosis in lesion-derived cells (LDCs) 9 and SMCs 10 by Fas/Fas ligand interactions. Fas-ligand-deficient mice show excessive vascular repair, 11 and Fas ligand-based gene therapy reduces intimal hyperplasia in animal models. 12, 13 Transcript profiling of human restenotic lesions observed activation of IFN␥ signaling, and IFN␥ receptor knockout mice have an attenuated neointimal response to injury, 14 consistent with an evolving theory that vascular diseases have a chronic inflammatory component. 15 Cells grown from fibrous regions of human vascular lesions contain both apoptosis-sensitive and resistant cells, but apoptosis-resistant cells quickly dominate the culture. 16 Transcript profiling of lesion cells revealed that increased expression of Bcl-X L is a major determinant of resistance to Fas-mediated apoptosis. 16, 17 Inflammatory cytokines, especially interferons, can increase the apoptotic response to Fas ligation in SMCs, 7, 18, 19 endothelial cells, 20 and other cell types. 21 The present studies used a microarray-based approach to identify factors that mediate the proapoptotic effect of IFN␥ on human LDCs.
Methods

Cells
Human atherosclerotic lesions were acquired by carotid endarterectomy by IRB-approved protocols. LDCs were isolated by explant of the fibrous cap and cultured in M199 with 10% fetal bovine serum (FBS) and gentamicin (50 g/mL). Microarray analysis 16, 22 and ␣-actin positivity 23 indicate that LDCs are SMC-like cells.
Apoptosis Assay: Small Molecule and siRNA Inhibition
The sensitivity to apoptosis was examined by determining survival after challenge with a Fas-activating IgM (clone CH11, Upstate Biotechnology). LDCs were plated at 50 K/24-well in M199ϩ10% FBS for 24 hours before overnight serum reduction to 1% FBS. Small molecule inhibitors, such as compstatin (Tocris Bioscience), pefabloc (BioChemika), cathepsin S inhibitor (Z-FL-COCHO, Calbiochem), MG132 (Z-Leu-Leu-Leu-al, Sigma), or epoxomycin (Sigma) were added 4 to 6 hours before IFN␥. LDCs were pretreated with siRNA pools (Dharmacon OnTargetPlus) containing 4 siRNAs in Dharmafect for 24 to 48 hours before IFN␥ treatment. IFN␥ (human recombinant, R&D Systems, 5 ng/50 IU/mL) was added for 20 to 24 hours before Fas-activating antibody (50 to 100 ng/mL). After 24 hours, MTT was added for 4 hours, the stained cells were dissolved in DMSO, and the level of reduced MTT was measured by O.D. at 570 nm in a plate reader. 24
Transcript Profiling
Genome-wide microarray profiling was conducted of IFN␥responsive transcripts in human LDCs in vitro. Total RNA was prepared using RNAzol B and Qiagen RNeasy Mini columns. RNA quantity was assessed by spectrometry and RNA quality was assessed by Agilent Bioanalyzer. Total RNA (10 g) was reverse transcribed, and biotin-labeled cRNA was produced by T7 in vitro transcription (IVT). Labeled cRNA was fragmented and hybridized to U133A GeneChips (Affymetrix, 22 282 transcripts). The IFN␥ response was evaluated in LDCs from 3 different patients.
Data Analysis
The raw data were summarized and normalized using GC-RMA in GeneSpring GX7. A paired t test identified 1500 transcripts, which were further filtered by a Ͼ1.5 fold-change and potential relevance to apoptosis. Gene lists were compared to published interferoninducible gene lists using LOLA. 25 Pathway analysis was conducted using Ingenuity Pathway Analysis (Ingenuity Systems).
Retroviral Overexpression
Full-length cDNA clones were obtained from Open Biosystems, or RT-PCR amplified from LDC mRNA. Inserts were subcloned into MSCV-IRES-eGFP retroviral vector, upstream of an encephalomyocarditis virus internal ribosome entry site (IRES) cassette linked to the enhanced green fluorescent protein (eGFP) reporter gene.
Quantitative RT-PCR
Quantitative RT-PCR (qRT-PCR) of candidate genes was conducted using SYBR Green fluorescence detected with an ABI 7300 realtime PCR. Standard dilutions of the cDNA were used to interpolate relative transcript abundance. HBOA and ZNF were used as control genes to compensate for minor variations in mRNA quality or quantity. Primer sequences are contained in supplemental Table I .
Western Blot Analysis
Protein lysates from untreated or IFN␥-treated cells were prepared with a protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktail (Sigma). Protein was quantified by BCA (Pierce), and 50 g of protein was run on a 12% SDS/PAGE gel and transferred to PVDF. Primary antibodies (supplemental Table III 
Results
Interferon␥ Sensitizes LDCs to Apoptosis in a Bcl-X L Reversible Manner
Like SMCs, 17, 18, 26 human LDCs are resistant to apoptosis induced by the Fas-activating CH11 IgM (50 ng/mL), causing Ͻ10% apoptosis (Figures 1, 3 , and 4). However, 24-hour pretreatment with IFN␥ (5 ng/mL) synergistically increases the apoptotic response to Fas ligation to 70% apoptosis. When the mitochondrial apoptosis pathway was suppressed with retroviral expression of Bcl-X L , 17 the small proapoptotic effect of IFN␥ alone was reduced, and the synergistic effect of IFN␥ and Fas ligation was eliminated ( Figure 1 ).
Transcript Profiling of IFN␥-Regulated Messages in LDCs
A full genome microarray profiling was conducted of IFN␥responsive transcripts in human LDCs in vitro. Using CRL1999 (ATCC) and radial artery smooth muscle as reference, the array data indicates that LDCs are transcriptpositive for 5 consensus smooth muscle markers: smooth muscle ␣-actin (ACTA2), smooth muscle myosin heavy chain (MYH11), calponin 1 (CNN1), aortic preferentially expressed protein 1 (APEG1), and SM22␣/transgelin (TAGLN). On IFN␥ treatment, the overwhelming majority of affected transcripts were induced (supplemental Figure I) , with some increases as much as 100-fold (INDO). A paired t test identified almost 1500 possible genes, which were further filtered by a Ͼ1.5 fold-change (135 transcripts), and potential relevance to apoptosis (72 transcripts, supplemental Table III ). These 72 transcripts were prioritized by the strength of their association to apoptosis, and their occurrence in other IFN␥ studies, using LOLA. 25
qRT-PCR Confirmation of Microarray Results
Many of the key IFN␥-regulated transcripts identified by microarray profiling were confirmed by qRT-PCR of LDCs treated with 5 ng/mL IFN␥ for 24 hours before total RNA isolation (supplemental Table III ). Essentially all transcripts with a greater than 1.5-fold change by microarray were confirmed by qRT-PCR. Marked changes in caspases 1 and 7, IRF-1, STAT1, and proteasome component mRNAs were confirmed, with smaller changes (1.6-fold) in Fas (CD95), caspase 3 and 4 levels, and essentially unchanged levels of caspase 8.
Identification of IRF-1 Inducible Messages and IRF-1 Effect on Apoptosis by Stable Overexpression
Many of the transcriptional effects of IFN␥ are mediated directly by STAT family members, and indirectly by induction of IRF-1, a potent transcription factor. IRF-1 was overexpressed in resistant LDCs to partially mimic the effect of IFN␥. The majority of IFN␥-inducible messages were induced to a similar degree by IRF-1 overexpression (supplemental Table III ). Consistent with prior reports, caspase 1 (interleukin converting enzyme [ICE]) 27 was strongly induced by IRF-1 expression. However, several transcripts were not elevated by IRF-1, such as Fas (CD95), which is regulated by IRF-8. 28 Notably, PSMB8 (LMP7) was not induced in IRF-1-expressing cells, whereas other members of the proteasome group were slightly increased in IRF-1 expressers (2-fold) but markedly less than that induced by IFN␥ (3.5-to 55-fold). Surprisingly, IRF-1 overexpression did not sensitize cells to apoptosis (not shown), and thus the IRF-1-induced transcripts can be excluded as candidate factors.
Western Blot Confirmation of Selected IFN␥-Inducible Proteins
Western blot analysis of the key proteins confirmed that antigen levels were elevated after IFN␥ treatment ( Figure 2 ). STAT1 protein was strongly elevated by IFN␥. Although Bcl-X L and Bcl-2 protein, potent antiapoptotic molecules, were only slightly decreased by IFN␥, their phosphorylated forms, p-Bcl-X L (ser62) and p-Bcl-2 (ser70), were more markedly decreased. P-Bcl-2 (ser70) is a more active antiapoptotic molecule, 29 whereas p-Bcl-X L (ser62) is less active. 30 Consistent with the strong elevation of its mRNA, caspase 1 (ICE) protein was strongly and consistently elevated by IFN␥. Both pro-and cleaved caspase 7 forms were elevated by IFN␥ treatment. Caspases 8, but not caspases 3 and 9, was slightly elevated by IFN␥. Fas levels were increased by IFN␥ although the levels in some untreated lines (E126) was greater than IFN␥-treated levels in other lines, suggesting that Fas levels alone do not determine sensitivity. Confirming prior work, 19 the cell surface expression of Fas, determined by flow cytometry, was increased 2-fold in IFN␥-treated cells, although among different cell lines Fas surface expression was poorly correlated with apoptotic sensitivity (not shown).
Despite a 2-fold increase in Mcl-1 mRNA levels, there was a marked decrease in Mcl-1 protein levels, which could be explained either by translational repression or increased ubiquitin-mediated proteosomal degradation. 31 Consistent with its mRNA levels, there was a marked increase in PSMB8/LMP7 protein antigen in IFN␥-treated cells.
Retroviral Overexpression of Candidate Apoptosis Modulators
A smaller set of candidate genes were examined by stable retroviral overexpression to evaluate their impact on apoptotic sensitivity. Surprisingly, caspase 1 (ICE), which has been reported to mediate apoptotic effects of interferon and IRFs 27 in other cell types, 32 did not alter sensitivity to Fas ligation when overexpressed in LDCs. 17 Other candidate transcripts: butrophylin (BTN3A3), caspase 7, ceramide kinase (CERK), G1P2, GBP1, IFITM1, phospholipid scramblase (PLSCR1), TRIM22, and VAMP4, were likewise ineffective.
Small-Molecule Inhibition
Certain IFN␥-induced targets were amenable to smallmolecule inhibition. The complement pathway was strongly modulated by IFN␥, with induction of C1QR1, C1R, C1S, C3, C4A, and H Factor 1 (HF1). However, compstatin (10 to 50 mol/L), a complement inhibitor, was ineffective at blocking the IFN␥ effect. Cathepsin S, which has known proapoptotic effects, was blocked with Z-FL-COCHO (0.02 to 2 mol/L, Calbiochem), but no effect on the IFN␥ response was observed. NK4/IL32 is a ligand and activator for PR3, a proapoptotic serine protease. PR3 was blocked by the serine protease inhibitor Pefabloc (1 to 100 mol/L), but apoptotic sensitivity was unaltered.
siRNA-Mediated Knockdown of Candidate Apoptotic Modulators
Using 4 siRNAs per target transcript, 14 candidate transcripts were targeted, including ADAR, ApoL6, caspase 7, caspase 9, CD47, CRADD/RAIDD, IL32/NK4, PKR, RIPK2, UBE1L, without abrogating the IFN␥-induced sensitization to apoptosis. However, as a positive control, siRNA-mediated knockdown of Bid completely blocked the IFN␥ effect (not shown).
siRNA Knockdown of PSMB8 Blocks IFN␥-Induced Sensitivity
Unlike the prior 14 candidates, which serve as excellent controls for nonspecific effects of siRNA, PSMB8/LMP7 knockdown clearly reversed IFN␥-induced sensitivity. As shown in Figure 3A , LDCs treated with 5 ng/mL of IFN␥ before Fas ligation (CH11, 50 ng/mL) show an increased sensitivity to apoptosis (83% survival reduced to 39% survival by INF␥) which is almost fully reversed (restored to 72% survival) by knockdown of PSMB8/LMP7 (50 nmol/L siRNA) but not by knockdown of PSME1 (PA28). A 1:1 mix of siRNA to PSMB8/LMP7 and PSME1 (25 nmol/L each) was equally effective at reversing the IFN␥ effect. Nontargeted siRNA did not alter the response to IFN␥. Further, knockdown of PSMB9 (LMP2) or PSMB10 (MECL1), or combined knockdown, was ineffective in blocking IFN␥induced sensitivity to Fas ligation (not shown). These experiments were repeated 5 times with similar results. The specificity of the siRNA effect was evaluated by qRT-PCR for the target transcripts and closely related members of the immunoproteasome. As shown in Figure 3B , the siRNA was very specific, reducing the IFN␥-induced target transcripts to below their basal levels with only minimal effects on other members of the immunoproteasome. For further confirmation, siRNA to PSMB8/LMP7 reduced IFN␥-induced PSMB8/LMP7 antigen to unstimulated levels, as shown in Figure 3C . However, neither PSME1 nor nontargeted siRNA blocked IFN␥-induced PSMB8/LMP7 antigen levels. Whereas PSMB8/LMP7 was essentially completely blocked, the induction of Fas antigen was not blocked by any of the siRNAs, and despite the elevated Fas levels, the PSMB8/LMP7 knockdown blocked sensitivity to apoptosis.
Mcl-1 Is Antiapoptotic for LDCs and Regulated by PSMB8/LMP7
To identify the specific apoptotic regulators that were modulated by PSMB8/LMP7, candidate factors with a known modulation by the proteasome were analyzed by Western blot. SiRNA knockdown of PSMB8 consistently elevated Mcl-1 protein levels, which was most pronounced with combined IFN␥/Fas challenge, compared to PSME1 or nontargeted siRNA ( Figure 4A ). The inhibitor of apoptosis proteins (IAP1, IAP2, XIAP), which have been previously described to be proteasome-regulated, 33 were not elevated by PSMB8 knockdown (IAP1 shown, Figure 4A ). Likewise, Bcl-2, pBcl-2, and pBcl-X L were not elevated by PSMB8/ LMP7 knockdown ( Figure 4A ).
To determine whether regulation of Mcl-1 levels was a viable mode of apoptotic regulation in LDCs, Mcl-1 was knocked down by siRNA and the effect on Fas-induced apoptosis was determined. Mcl-1 knockdown reduced survival by approximately 50% and increased the apoptotic response to Fas ligation from 32% to 55%, yielding a combined increase in killing from 32% to 77% ( Figure 4B , left). Western blot confirmed essentially complete knockdown of Mcl-1 antigen without an effect of a nontargeted control siRNA (siCon). Conversely, retroviral overexpression of Mcl-1 markedly reduced the sensitivity to apoptosis (72% to 46% death) in the presence of IFN␥ ( Figure 4B, right) . However, the IFN␥-induced degradation of Mcl-1 severely limited the degree to which Mcl-1 could be overexpressed, as measured by Western blot ( Figure 4B ). Thus, Mcl-1 is a potent survival factor, and Mcl-1 levels are increased by PSMB8 knockdown.
Mcl-1 Levels Are Protected by Proteasome Inhibition
To confirm that Mcl-1 is proteasomally degraded, LDCs were IFN␥-treated in the presence or absence of proteasome inhibitors for 24 hours before protein harvest. Cotreatment with IFN␥ and MG132 or epoxomycin strikingly increased levels of Mcl-1 above untreated levels and modestly increased the levels of p-Bcl-2 and p-Bcl-X L (Figure 5 ). After proteasome inhibition, p-Bcl-2 antigen accumulates in higher mass forms consistent with ubiquitinated protein.
Discussion
The control of apoptosis during vascular repair may be a key determinant of both lesion progression and plaque rupture. Thus, understanding the immune and inflammatory influences on apoptosis in vascular cells may facilitate preventative and therapeutic strategies. A systematic examination of potential IFN␥ targets revealed the unexpected role of the immunoproteasome component PSMB8/LMP7 as a major component of IFN␥-induced sensitivity. The immunoproteasome has been almost exclusively studied in the context of its role in antigen presentation, although recent studies in double MECL1-and LMP7-deficient T cells suggests that T cell proliferation is also affected by immunoproteasome activity. 34 PSMB8/LMP7 is a well-known stress 35 and IFN␥inducible component of the immunoproteasome. The PSMB8 protein product, LMP7, replaces the constitutive ß5 subunit, hence its alternate designation as ß5i. PSMB8 has been reported to be induced by IFN␥ through IRF-1, 36 although our promoter analysis indicates there is only a single IRF-1 site (Ϫ2580 to TSS), but 5 STAT sites (Ϫ4574, Ϫ4563, Ϫ3406, Ϫ2160, Ϫ1148), 37 which is consistent with the present data that IRF-1 overexpression did not induce PSMB8, whereas IFN␥ strongly induced it (Ͼ10ϫ). As shown in Figure 6 , the 3 catalytic units of the constitutive proteasome are replaced after IFN␥ treatment, as well as key changes to the regulatory subunits (PA28 ␣ and ß). The result is an "immuno"proteasome which cleaves proteins into short peptide antigens for presentation by MHC I. 38 The immunoproteasome, however, can activate NFB and degrade IB. 39 The present results suggest a straightforward mechanism for the apoptotic sensitivity associated with immunoproteasome induction. Mcl-1, a potent prosurvival factor, is ubiquitinated by the MULE ubiquitin ligase and degraded by the proteasome. 31, 40 Although other substrates could be affected, it is clear that induction of immunoproteasome activity accelerates Mcl-1 degradation, thereby reducing the survival ability of the cell. Evidence from siRNA knockdown of PSMB8, Mcl-1, and overexpression of Mcl-1 strongly suggests a significant role for this mechanism in mediating the proapoptotic effects of IFN␥ via the immunoproteasome. Additional effects of IFN␥ on p-Bcl-2 and Fas receptor levels may also contribute importantly to the overall sensitivity to apoptosis.
Consistent with a possible in vivo relevance for the present results, important changes in the ubiquitin-proteasome system are observed in age-related atherosclerosis. 41 Stroke-prone unstable carotid artery lesions exhibit elevated inflammatory markers and increased proteasome activity. 42 There are wellknown changes in proteasome and immunoproteasome activities during the aging process, 43, 44 which might result from inflammatory stimuli, interferon activity, and result in altered apoptotic sensitivity. Likewise, changes in the immunoproteasome response to interferon is a feature of senescent cells. 45 Although a general connection between inflammation, atherosclerosis, and myocardial infarction is well established, the precise molecular connections are only beginning to be elucidated. For instance, epidemiological evidence suggests that influenza infection is a strong risk for myocardial infarction. 46 Likewise, influenza 47 and other viral infections 48 are potent activators of the immunoproteasome. Combined, the present results identify a novel and potentially important connection between immune activation and the control of vascular apoptosis.
